학술논문

Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes
Document Type
article
Source
Journal of Hepatology. 73(3)
Subject
Reproductive Medicine
Biomedical and Clinical Sciences
Digestive Diseases
Prevention
Liver Disease
Contraception/Reproduction
Chronic Liver Disease and Cirrhosis
Preterm
Low Birth Weight and Health of the Newborn
Pediatric
Perinatal Period - Conditions Originating in Perinatal Period
Infant Mortality
Hypertension
Clinical Research
Reproductive health and childbirth
Good Health and Well Being
Adult
Comorbidity
Diabetes
Gestational
Eclampsia
Female
Fetal Death
Gestational Age
Humans
Infant
Newborn
Maternal Mortality
Non-alcoholic Fatty Liver Disease
Postpartum Hemorrhage
Pre-Eclampsia
Pregnancy
Premature Birth
Prevalence
Retrospective Studies
United States
Non-alcoholic steatohepatitis
Reproductive health
Complications
Chronic liver disease
Clinical Sciences
Public Health and Health Services
Gastroenterology & Hepatology
Clinical sciences
Language
Abstract
Background & aimsThe prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear.MethodsUsing weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension.ResultsAmong 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p